D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PNT holding history
POINT Biopharma Global Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PNT overviewAll 13F holders of PNTFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −167,955−100.0% | Sold out | Holders |
| Q3 2023 | 167,955 | $1.12M | <0.1% | +29,781+21.6% | Added | Holders |
| Q2 2023 | 138,174 | $1.25M | <0.1% | +138,174 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −43,744−100.0% | Sold out | Holders |
| Q1 2022 | 43,744 | $349.0K | <0.1% | −39,308−47.3% | Reduced | Holders |
| Q4 2021 | 83,052 | $465.0K | <0.1% | +20,170+32.1% | Added | Holders |
| Q3 2021 | 62,882 | $484.0K | <0.1% | +62,882 | New | Holders |